**Question:** ACE inhibitors should not be used with?

**Core Concept:** ACE inhibitors are a class of medications commonly used in the treatment of hypertension, heart failure, and diabetic nephropathy. Angiotensin-converting enzyme inhibitors (ACEIs) work by blocking the conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction, aldosterone secretion, and sodium retention, ultimately leading to vasodilation and decreased blood pressure.

**Why the Correct Answer is Right:** The correct answer is "Angiotensin II Receptor Blockers (ARBs)" because they work by blocking the action of angiotensin II at its receptor sites, leading to similar effects as ACE inhibitors. Combining ACEIs and ARBs can result in a phenomenon called "crossover," where the increased angiotensin II levels due to ACEI blockade activate the angiotensin II receptors, leading to a decrease in blood pressure.

**Why Each Wrong Option is Incorrect:**

A. **Angiotensinogen:** Angiotensinogen is a precursor for angiotensin II, not a receptor. Therefore, it is irrelevant to the interaction between ACEIs and ARBs.

B. **Diuretics:** Diuretic medications help increase urine output and reduce blood volume, which directly opposes the effects of ACEIs and ARBs. However, they do not directly affect the interaction between these two classes of medications.

C. **Nitrates:** Nitrates are vasodilators that lower blood pressure by increasing blood flow and reducing peripheral resistance. Although they can be used in combination with ACEIs or ARBs, the correct answer is still ARBs because of the crossover phenomenon.

D. **Angiotensin II:** Angiotensin II is a peptide hormone that acts as a vasoconstrictor and promotes aldosterone release, leading to increased blood pressure. However, it is not the receptor targeted by ACEIs and ARBs, making it irrelevant to the interaction between these two classes of medications.

**Clinical Pearls:** In clinical practice, caution is advised when combining ACEIs and ARBs, as this combination can lead to a reduction in blood pressure, potentially causing hypotension in certain patients, especially those with low blood pressure or those receiving both medications for the first time.

**Explanation:**

Angiotensin II acts on two primary receptors:

1. Angiotensin II Type 1 Receptor (AT1R): Angiotensin II binding to AT1R leads to vasoconstriction, aldosterone secretion, and fibrosis.
2. Angiotensin II Type 2 Receptor (AT2R): Angiotensin II binding to AT2R causes vasodilation, reduces aldosterone secretion, and promotes anti-fibrotic effects.

When ACEIs (such as enalapril) and ARBs (such as losartan) are combined, angiotensin II levels increase, as both medications work on the same pathway. Angiotensin II then binds to the AT1R, causing vasoconstriction, aldosterone secretion, and